The non dilutive funding potential just got bigger and partnership with the Walter Reed US army institute on secondary Brian injury in war, makes NYR even more valuable on safety clearence in humans coming up with wars in the Middle East looking to remain for the years to come
Ann: Significant Neuroprotection in Traumatic Brain Injury Study, page-26
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $61.32M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 28.0¢ | $169.3K | 596.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 115000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 66300 | 3 |
View Market Depth
| Last trade - 11.51am 07/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |